Bioprocessing

First commercial cell culture solution tailored for HEK293 cells in perfusion, enabling high-density growth, scalable viral vector production, and consistent quality for advanced therapies.

The collaboration highlights growing efforts to overcome manufacturing hurdles in gene therapy and bring treatments for debilitating neuromuscular junction diseases closer to patients.

The 128,000-sq-ft GMP cell and gene therapy facility in New Jersey, expands the CDMOs U.S. capabilities in plasmid, AAV, and LVV manufacturing.

Fujifilm has rebranded key life sciences companies under a unified "Partners for Life" strategy to offer integrated, end-to-end solutions across the drug development lifecycle.

Exploring the shift towards digitalisation in bioprocessing, from AI and cloud-based systems to overcoming challenges like regulatory hurdles, cost, and standardisation, while driving efficiency, compliance, and collaboration in bioprocessing.

SolarBiotech, GPC Bio, and Eleszto Genetika have merged to form a fully integrated leader in synthetic biology and biomanufacturing, combining their expertise to streamline the development and commercialization of sustainable biotechnologies.